1 |
Pellegrini M, Bergonzoni G, Perrone F, Squitieri F, Biagioli M. Current Diagnostic Methods and Non-Coding RNAs as Possible Biomarkers in Huntington’s Disease. Genes 2022;13:2017. [DOI: 10.3390/genes13112017] [Reference Citation Analysis]
|
2 |
Zhang Y, Niu C. Relation of CDC42, Th1, Th2, and Th17 cells with cognitive function decline in Alzheimer's disease. Ann Clin Transl Neurol 2022. [PMID: 35976992 DOI: 10.1002/acn3.51643] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
3 |
Seefelder M, Klein FAC, Landwehrmeyer B, Fernández-Busnadiego R, Kochanek S. Huntingtin and Its Partner Huntingtin-Associated Protein 40: Structural and Functional Considerations in Health and Disease. J Huntingtons Dis 2022. [PMID: 35871360 DOI: 10.3233/JHD-220543] [Reference Citation Analysis]
|
4 |
Kim C, Yousefian-Jazi A, Choi SH, Chang I, Lee J, Ryu H. Non-Cell Autonomous and Epigenetic Mechanisms of Huntington's Disease. Int J Mol Sci 2021;22:12499. [PMID: 34830381 DOI: 10.3390/ijms222212499] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
5 |
Huang B, Seefelder M, Buck E, Engler T, Lindenberg KS, Klein F, Landwehrmeyer GB, Kochanek S. HAP40 protein levels are huntingtin-dependent and decrease in Huntington disease. Neurobiol Dis 2021;158:105476. [PMID: 34390835 DOI: 10.1016/j.nbd.2021.105476] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|